BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 23150683)

  • 1. A retrospective cohort analysis of the efficacy of adjuvant radiotherapy after primary surgical resection in patients with adrenocortical carcinoma.
    Habra MA; Ejaz S; Feng L; Das P; Deniz F; Grubbs EG; Phan A; Waguespack SG; Ayala-Ramirez M; Jimenez C; Perrier ND; Lee JE; Vassilopoulou-Sellin R
    J Clin Endocrinol Metab; 2013 Jan; 98(1):192-7. PubMed ID: 23150683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma.
    Sabolch A; Else T; Griffith KA; Ben-Josef E; Williams A; Miller BS; Worden F; Hammer GD; Jolly S
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):252-9. PubMed ID: 25754631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of adjuvant radiotherapy of the tumor bed on local recurrence of adrenocortical carcinoma.
    Fassnacht M; Hahner S; Polat B; Koschker AC; Kenn W; Flentje M; Allolio B
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4501-4. PubMed ID: 16895957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma.
    Gharzai LA; Green MD; Griffith KA; Else T; Mayo CS; Hesseltine E; Spratt DE; Ben-Josef E; Sabolch A; Miller BS; Worden F; Giordano TJ; Hammer GD; Jolly S
    J Clin Endocrinol Metab; 2019 Sep; 104(9):3743-3750. PubMed ID: 31220287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-Term Outcomes of Adjuvant Mitotane Therapy in Patients With Radically Resected Adrenocortical Carcinoma.
    Berruti A; Grisanti S; Pulzer A; Claps M; Daffara F; Loli P; Mannelli M; Boscaro M; Arvat E; Tiberio G; Hahner S; Zaggia B; Porpiglia F; Volante M; Fassnacht M; Terzolo M
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1358-1365. PubMed ID: 28324035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Adjuvant Mitotane after Resection of Adrenocortical Carcinoma: A 13-Institution Study by the US Adrenocortical Carcinoma Group.
    Postlewait LM; Ethun CG; Tran TB; Prescott JD; Pawlik TM; Wang TS; Glenn J; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Staley CA; Poultsides GA; Maithel SK
    J Am Coll Surg; 2016 Apr; 222(4):480-90. PubMed ID: 26775162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of adjuvant radiotherapy for treatment of adrenocortical carcinoma: a retrospective study and an updated meta-analysis.
    Zhu J; Zheng Z; Shen J; Lian X; Miao Z; Shen J; Zhang F
    Radiat Oncol; 2020 May; 15(1):118. PubMed ID: 32448148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of adjuvant radiation therapy in localized adrenocortical carcinoma.
    Wu L; Chen J; Su T; Jiang L; Han Y; Zhang C; Zhou W; Jiang Y; Zhong X; Wang W
    Front Endocrinol (Lausanne); 2023; 14():1308231. PubMed ID: 38260140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benefit of Postoperative Radiotherapy for Patients With Nonmetastatic Adrenocortical Carcinoma: A Population-Based Analysis.
    Wu K; Liu X; Liu Z; Lu Y; Wang X; Li X
    J Natl Compr Canc Netw; 2021 Dec; 19(12):1425-1432. PubMed ID: 34902831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgery for recurrent adrenocortical carcinoma: A multicenter retrospective study.
    Simon G; Pattou F; Mirallié E; Lifante JC; Nominé C; Arnault V; de Calan L; Caillard C; Carnaille B; Brunaud L; Laplace N; Caiazzo R; Blanchard C
    Surgery; 2017 Jan; 161(1):249-256. PubMed ID: 27855966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant mitotane treatment for adrenocortical carcinoma.
    Terzolo M; Angeli A; Fassnacht M; Daffara F; Tauchmanova L; Conton PA; Rossetto R; Buci L; Sperone P; Grossrubatscher E; Reimondo G; Bollito E; Papotti M; Saeger W; Hahner S; Koschker AC; Arvat E; Ambrosi B; Loli P; Lombardi G; Mannelli M; Bruzzi P; Mantero F; Allolio B; Dogliotti L; Berruti A
    N Engl J Med; 2007 Jun; 356(23):2372-80. PubMed ID: 17554118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane.
    Grubbs EG; Callender GG; Xing Y; Perrier ND; Evans DB; Phan AT; Lee JE
    Ann Surg Oncol; 2010 Jan; 17(1):263-70. PubMed ID: 19851811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Borderline resectable adrenal cortical carcinoma: a potential role for preoperative chemotherapy.
    Bednarski BK; Habra MA; Phan A; Milton DR; Wood C; Vauthey N; Evans DB; Katz MH; Ng CS; Perrier ND; Lee JE; Grubbs EG
    World J Surg; 2014 Jun; 38(6):1318-27. PubMed ID: 24615603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant radiotherapy for the primary treatment of adrenocortical carcinoma: Are we offering the best?
    Srougi V; de Bessa J; Tanno FY; Ferreira AM; Hoff AO; Bezerra JE; Almeida CM; Almeida MQ; Mendonça BB; Nahas WC; Chambô JL; Srougi M; Fragoso MCBV
    Int Braz J Urol; 2017; 43(5):841-848. PubMed ID: 28727379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to radiation therapy in adrenocortical carcinoma.
    Hermsen IG; Groenen YE; Dercksen MW; Theuws J; Haak HR
    J Endocrinol Invest; 2010 Nov; 33(10):712-4. PubMed ID: 20220294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and definitive radiotherapy for adrenocortical carcinoma.
    Sabolch A; Feng M; Griffith K; Hammer G; Doherty G; Ben-Josef E
    Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1477-84. PubMed ID: 20675074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved survival in patients with stage II adrenocortical carcinoma followed up prospectively by specialized centers.
    Fassnacht M; Johanssen S; Fenske W; Weismann D; Agha A; Beuschlein F; Führer D; Jurowich C; Quinkler M; Petersenn S; Spahn M; Hahner S; Allolio B;
    J Clin Endocrinol Metab; 2010 Nov; 95(11):4925-32. PubMed ID: 20668036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after resection of cortisol-secreting adrenocortical carcinoma.
    Margonis GA; Kim Y; Tran TB; Postlewait LM; Maithel SK; Wang TS; Glenn JA; Hatzaras I; Shenoy R; Phay JE; Keplinger K; Fields RC; Jin LX; Weber SM; Salem A; Sicklick JK; Gad S; Yopp AC; Mansour JC; Duh QY; Seiser N; Solorzano CC; Kiernan CM; Votanopoulos KI; Levine EA; Poultsides GA; Pawlik TM
    Am J Surg; 2016 Jun; 211(6):1106-13. PubMed ID: 26810939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes following surgical management of adrenocortical carcinoma: A single-center experience.
    Turco M; Huguet J; Territo A; Fontana M; Rodriguez Faba O; Palou J; Breda A
    Arch Esp Urol; 2021 Oct; 74(8):782-789. PubMed ID: 34605409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National Treatment Practice for Adrenocortical Carcinoma: Have They Changed and Have We Made Any Progress?
    Tierney JF; Chivukula SV; Poirier J; Pappas SG; Schadde E; Hertl M; Kebebew E; Keutgen X
    J Clin Endocrinol Metab; 2019 Dec; 104(12):5948-5956. PubMed ID: 31361313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.